Home / Health / TAVR Heart Valve Failure: Younger Patients at Risk?
TAVR Heart Valve Failure: Younger Patients at Risk?
24 Apr
Summary
- TAVR valves may fail earlier than expected in younger patients.
- Some patients who received TAVR now require open heart surgery.
- TAVR was initially for frail patients but now used in healthier ones.
Transcatheter aortic valve replacement (TAVR), a groundbreaking cardiovascular innovation approved in 2011, is increasingly being used for younger and healthier individuals. While initially intended for frail, elderly patients, its use has expanded to lower-risk groups. However, concerns are surfacing regarding the long-term durability of these TAVR valves, especially in younger, more active patients.
Some patients, like Susan Glannan who received a TAVR in 2021, are experiencing valve malfunction and leakage within a few years. This has led to them needing further interventions, including open-heart surgery, defeating the procedure's original purpose. Medical experts emphasize that the choice between TAVR and surgical aortic valve replacement should hinge on a patient's individual health and life expectancy.
Studies suggest that TAVR valves, often made of animal tissue, may deteriorate faster in younger patients. This raises questions about optimal long-term outcomes, as many younger patients are likely to outlive the lifespan of the implanted valve. Ongoing research is critical to understanding the full implications for this growing patient population.
